Previous Close | 28.19 |
Open | 27.83 |
Bid | 28.31 x 51100 |
Ask | 28.40 x 25600 |
Day's Range | 27.80 - 28.42 |
52 Week Range | 21.14 - 36.37 |
Volume | |
Avg. Volume | 2,147,421 |
Market Cap | 41.656B |
Beta (5Y Monthly) | 0.67 |
PE Ratio (TTM) | 30.13 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 0.29 (1.03%) |
Ex-Dividend Date | Feb 07, 2024 |
1y Target Est | N/A |
SAN DIEGO, April 04, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2024 on Thursday, April 25, 2024, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: • Location:http://investor.resmed.com • Da
36,000 people across 17 markets responded to the company’s fourth annual survey.40% of respondents get no more than three nights of good sleep per week.More than one-third of respondents are now actively tracking their sleep patterns, and many are adjusting bedtime routines in an effort to improve sleep quality. SAN DIEGO, March 15, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD), the global leader in digital health and cloud-connected medical devices that transform care for people with sl
Enhances sleep apnea therapy by combining the ease and comfort of an ultra-compact, under-the-nose full-face design with the effectiveness of a traditional over-the-nose full-face mask.Featuring the AdaptiSeal™ cushion made of 100% soft silicone to adapt to various facial contours, allowing for a secure and comfortable seal throughout the night. 96% of patients using the AirFit F40 said they have the freedom to sleep in their preferred position and change positions through the night.1 SAN DIEGO,